Navigation Links
PDI, Inc. Announces New Multi-Year Win Valued At up to $150 Million and Provides Outlook for 2012
Date:10/25/2012

PARSIPPANY, N.J., Oct. 25, 2012 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced the signing of a new multi-year Sales Services contract with a Top 5 global pharmaceutical company to provide a dedicated sales team that will target primary care physicians, pediatricians and psychiatrists. The contract is expected to generate revenue to PDI of approximately $48 million in 2013 and up to $150 million over the life of the agreement. The FDA-approved product is expected to be marketed beginning early in the first quarter of 2013 after completion of certain non-FDA regulatory approvals and third party agreements. PDI expects to record less than $1 million of revenue from this contract in the fourth quarter of 2012.  In addition to the Sales Services contract, PDI will be providing services to deliver HCP digital communications in support of the product through PDI's Group DCA division.  

"This new major win affirms the value we provide to our customers," said Nancy Lurker, Chief Executive Officer of PDI, Inc. "At PDI, we focus on providing customers with a high return on their investment in our outsourcing services and the strategic flexibility to make the most effective use of their resources."

2012 Outlook:

As a part of PDI's ongoing focus on cost reduction, the company continues to streamline its operations.  As a result, the company expects to record charges in the fourth quarter for severance of approximately $1.0 million and facilities realignment of approximately $1.1 million. 

"Including the contract win we announced today, we have won more than $250 million of new contracts and renewals in 2012," said Lurker. "Due to the timing of these wins and the execution timelines of these contracts we expect that only approximately $40 million will impact revenue in 2012 however, we expect to be entering 2013 with a strong backlo
'/>"/>

SOURCE PDI, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("HMP"), its drug R&D subsidiary, successfully achieved the ... of fruquintinib in patients with advanced non-squamous non-small ... .  The top-line results demonstrated that the ... endpoint of progression free survival ("PFS"). ...
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... successfully used to save millions of lives across globe. ... the Kingdom of Saudi Arabia . ... raw material suppliers, government agencies and regulatory bodies. The ... been studied from two perspectives: by products and by ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... 15, 2012 For the 35 million people ... new, fast, effective approach to treatment is now ... light, radiofrequency and ultrasound aesthetic and medical devices, ... newest innovation for the Harmony(XL) multi-application, multi-technology platform, ...
... BARCELONA, Spain, March 15, 2012 Grifols (MCE:GRF, MCE:GRF.P ... largest plasma product manufacturer and a pioneer in the ... to both scientific and social development, has acquired 51% ... the viability of its projects and the future of ...
Cached Medicine Technology:New Nail Fungus Approach Receives FDA Clearance 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 3Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 4Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 5Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 6Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 7Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 8
(Date:9/5/2015)... ... ... Doctors in Chicago have published a new study on the outcomes of ... just posted an article on the research on its website. Click here to ... retrospective analysis of 117 mesothelioma patients who underwent extended pleurectomy between 2008 and 2013. ...
(Date:9/4/2015)... , ... September 05, 2015 , ... Paradise Valley ... China for an exclusive, one-night exhibition of their work at Paradise Valley Community College. ... Friday, September 18, from 6-9 pm. The artists will be on hand to meet ...
(Date:9/4/2015)... ... September 04, 2015 , ... On the heels ... doubled the size of its annual health tech innovation program. Now featuring a ... startups to compete for cash and prizes to advance their technologies toward commercialization, ...
(Date:9/4/2015)... ... , ... The Providence Fertility Center will host a Fertility Cocktail Hour" in ... , Date and Time: October 8, 2015 at Waterman Grille restaurant and lounge, 4 ... will discuss the basics of female fertility and egg freezing, and offer women a ...
(Date:9/4/2015)... NC (PRWEB) , ... September 04, 2015 , ... ... the Consumer Health Products Association (CHPA) joint meeting of its Product, Quality and ... for hazardous waste handling rules constantly evolving in the consumer goods industry, it ...
Breaking Medicine News(10 mins):Health News:New Study Appears to Validate the Safety of Mesothelioma Surgery for Older Patients, According to Surviving Mesothelioma 2Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3
... The Ensign,Group, Inc. (Nasdaq: ENSG ), the ... rehabilitative care services and assisted living,companies, announced today ... 2008,financial results following the market close on Thursday, ... Conference Call, Ensign invites current and ...
... to Accelerate Disability Determinations, WASHINGTON, Oct. ... the Social Security Administration,s,new "Compassionate Allowances Process" ... of disability claims. Before announcing this,proposal, Social ... of 2008 to,receive information from experts. NPAF, ...
... cholesterol-lowering statins is associated with a statistically significant decline ... report in the October 28 online issue of the ... Previous studies examined whether statin use was associated with ... have been inconsistent. Few studies have examined the association ...
... Balm with a Slant-Tipped Applicator Now Available ... Exclusively at Walgreens and Walgreens.com, ... Carmex(R) lip balm products, today announced the arrival of ... protection with vitamin E, aloe, shea butter and avocado,butter. ...
... that block tumor necrosis factor and malignancies , , ... used to treat rheumatoid arthritis (RA), don,t appear to ... more than 4,000 RA patients treated with the biologics. ... and given to more than 600,000 people worldwide, interfere ...
... Interference with ... Prospective Business Advantage, CAMBRIDGE, Mass., Oct. 28 ... had filed an action for injunctive,relief and damages against Charles ... hemoglobin glutamer-250,(bovine), Biopure,s oxygen therapeutic product for human use. The ...
Cached Medicine News:Health News:The Ensign Group Schedules 2008 Third Quarter Earnings Call for Friday, October 31, 2008 2Health News:National Patient Advocate Foundation (NPAF) Commends SSA's New 'Compassionate Allowances Process' 2Health News:Statin use associated with reduction in prostate specific antigen levels 2Health News:Biologics Don't Raise Cancer Risk in Rheumatoid Arthritis Patients 2Health News:Biopure Sues National Institutes of Health Official 2Health News:Biopure Sues National Institutes of Health Official 3
... Bactericide, Microbicide for professional degerming, pre-op ... skin disinfectants combining quaternary and substituted ... blend of emollients and surfactants. Unprecedented ... organisms tested in 30 seconds. Techni-Care ...
... bonds with the skin ... germ-killing field. In addition ... antimicrobial effect, HIBICLENS' non-drying, ... promotes compliance with the ...
... ACTIPREP, the one-step prep solution, allows the ... and applies and dries in less than ... technology commonly used in surgical scrubbing and ... film-former added to help provide a tacky ...
... contains 10% Povidone Iodine USP, 1% available ... pre-operative prep, Povidone Iodine Gel helps to ... the patient, thus reducing the chance of ... as a one step gel for venipuncture ...
Medicine Products: